Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease

ClinicalTrials.gov ID: NCT01241344

Public ClinicalTrials.gov record NCT01241344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 10:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled, Multi-site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment With CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study was designed to assess the safety and efficacy of preemptive treatment with oral brincidofovir (BCV), as compared to placebo, for the prevention of adenovirus (AdV) disease in recipients of hematopoietic stem cell transplantation (HCT) with asymptomatic AdV viremia.

Study identification

NCT ID
NCT01241344
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
52 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
3 Months to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Actual)
Primary completion
Jun 2013 (Actual)
Completion
Jun 2013 (Actual)
Last update posted
Jul 21, 2021

2010 – 2013

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233 —
Pheonix Children's Hospital Phoenix Arizona 85016 —
City of Hope National Medical Center Duarte California 91010 —
Childrens hospital of LA Los Angeles California 90033 —
CHOC Children's Hospital Orange California 92868 —
University of California, San Francisco San Francisco California 94143 —
Lucile Packard Childrens hopsital at Stanford Stanford California 94304 —
The Children's Hospital-Denver Aurora Colorado 80045 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Indiana University Indianapolis Indiana 46202 —
LSU Health Sciences Center New Orleans Childrens Hospital New Orleans Louisiana 70118 —
Harvard-Children's Hospital Boston Boston Massachusetts 02115 —
Univeristy of Minnesota Minneapolis Minnesota 55455 —
St. Louis Children's Hosptial St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Memorial Sloan Kettering New York New York 10021 —
New York Medical College Valhalla New York 10595 —
Duke University Medical Center Durham North Carolina 27710 —
Cincinnati Childrens Hospital Cincinnati Ohio 45229 —
Cleveland Clinic Cleveland Ohio 44195 —
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
St. Judes Children's Research Hospital Memphis Tennessee 38105 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
UT Southwestern Dallas Texas 75390 —
Baylor College of Medicine, Texas Childrens Hospital Houston Texas 77030 —
MD Anderson Cancer Center Houston Texas 77030 —
Methodist Hospital San Antonio Texas 78229 —
Primary Children's Medical of Utah Salt Lake City Utah 84113 —
Seattle Cancer Care Alliance Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01241344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2021 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01241344 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →